Trends In Illicit Substance Use By Students and Young People In the European Union According to ESPAD

"Generally, between 1995 and 2011, there was an increase in the lifetime prevalence of illicit drug use, most of which occurred between 1995 and 1999. Since 2011, the prevalence has started to decrease slowly. The lifetime prevalence of illicit drug use among boys and girls follows a parallel trend, with the rate among girls being about 5-6 percentage points lower than that among boys (Figure 21).

Drug Use By Students and Young People in the European Union According to ESPAD

"Lifetime use of illicit drugs varied considerably across the ESPAD countries (Table 8a). On average, 17% of ESPAD students reported having used any illicit drug at least once. The highest percentage of students reporting lifetime use of any illicit drug was found in Czechia (29%), followed by Italy (28%), Latvia (27%) and Slovakia (25%). Particularly low levels (10% or less) of illicit drug use were noted in Kosovo, Iceland, North Macedonia, Ukraine, Serbia, Sweden, Norway, Greece and Romania.

"High-Risk" Drug Use In Sweden

"Studies reporting estimates of high-risk drug use can help to identify the extent of the more entrenched drug use problems, while data on first-time entrants to specialised drug treatment centres, when considered alongside other indicators, can inform an understanding of the nature of and trends in high-risk drug use.
"A 2011 study estimated that there were 8 000 people who inject drugs in Sweden, the majority of whom used opioids and/or amphetamine. There is no national estimate on the prevalence of high-risk drug use by substance.

Prevalence of Drug Use Among Young People in Sweden

"In the 2016 survey, 4% of 16-year-olds and 13% of 18-year-olds responded that they had used drugs in the past 12 months (Tables 39–40). In a broader group of young adults (16–29 years), about 8% said they had used cannabis in the past year (Table 45). Viewed in a 45-year perspective, it is mainly the 1980s that stand out, with a lower percentage reporting personal experience of illicit drug use.

Prevalence of drug use in Sweden

"Cannabis remains the illicit substance most commonly used in Sweden. However, lifetime prevalence of cannabis use among the general population remains low in comparison with other European countries. The data indicate that cannabis use is concentrated among young adults, in particular those aged 15-24 years. The long-term trend analysis shows a slight increase in last year cannabis use over the past decade among 16- to 34-years-olds. In general, cannabis use is more common among males than females.

Prevalence of Chronic Pain in the US

"To estimate the prevalence of chronic pain and high-impact chronic pain in the United States, CDC analyzed 2016 National Health Interview Survey (NHIS) data. An estimated 20.4% (50.0 million) of U.S. adults had chronic pain and 8.0% of U.S. adults (19.6 million) had high-impact chronic pain, with higher prevalences of both chronic pain and high-impact chronic pain reported among women, older adults, previously but not currently employed adults, adults living in poverty, adults with public health insurance, and rural residents."

How Many People In The US Are In Recovery?

"Summarizing data from six large studies, one analysis estimated that the proportion of the United States adult population that is in remission from a substance use disorder of any severity is approximately 10.3 percent (with a range of 5.3 to 15.3 percent).29 This estimate is consistent with findings from a different national survey, which found that approximately 10 percent, or 1 in 10, of United States adults say, 'Yes,' when asked, 'Did you once have a problem with drugs or alcohol but no longer do?' These percentages translate to roughly 25 million United States adults being

Estimated Prevalence of Drug Use Disorder in the United States

"In 2012–2013, the NESARC-III [National Epidemiologic Survey on Alcohol and Related Conditions–III], a large national survey of US adults, assessed 12-month and lifetime disorders, including DUDs, diagnosed according to the new DSM-5. The NESARC-III used rigorous survey and field methods and incorporated measures of functioning and detailed assessments of treatment use. The NESARC-III results indicate that the prevalence rates of 12-month and lifetime DSM-5 DUD were 3.9% and 9.9%, respectively, representing approximately 9,131,250 and 23,310,135 US adults, respectively.